HeartBeam (BEAT)
(Real Time Quote from BATS)
$1.98 USD
+0.02 (1.02%)
Updated May 13, 2024 01:52 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
BEAT 1.98 +0.02(1.02%)
Will BEAT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BEAT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for BEAT
HeartBeam AIMIGoâ„¢ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
HeartBeam, Inc. 2024 Q1 - Results - Earnings Call Presentation
HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript
HeartBeam Reports First Quarter 2024 Results
BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024